Search - tctmd.com

Displaying 701 - 720 of 1046

Sort: Relevancy | Date

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Todd Neale

December 14, 2015

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

Muchos Pacientes sin Recursos Dejan de Tomar Clopidogrel Post-PCI

Todd Neale

December 10, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Daily News

与他汀类药物相关的负面新闻与停药和心血管风险增加有关

Michael O'Riordan

December 02, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Daily News

Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV

Michael O'Riordan

December 02, 2015

Presentation

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Presenter: Sune Nielsen

December 01, 2015

News Conference News AHA 2015

Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact

Todd Neale

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Conference News AHA 2015

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Yael L. Maxwell

November 08, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV

L.A. McKeown

November 03, 2015

News Daily News

A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM

Yael L. Maxwell

October 30, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

Yael L. Maxwell

October 26, 2015

News Conference News TCT 2015

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Yael L. Maxwell

October 16, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

Advertisement

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Muchos Pacientes sin Recursos Dejan de Tomar Clopidogrel Post-PCI

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

与他汀类药物相关的负面新闻与停药和心血管风险增加有关

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV

A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Discussion Highlights Merits, Limitations of Small Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content